Engineering topics

Kohri, K.

Publications and source records attributed to Kohri, K..

6 records

DOE OSTI2025

Requirements on the gain calibration for LiteBIRD polarisation data with blind component separation

The detection of primordial B modes of the cosmic microwave background (CMB) could provide information about the early stages of the Universe's evolution. The faintness of this signal requires exquisite calibration accuracy and control of instrumental systematic effects which otherwise could bias the measurements. In this work, we study the impact of an imperfect relative polarisation gain calibration on the recovered value of the tensor-to-scalar ratio r for the LiteBIRD experiment, through the application of the blind Needlet Internal Linear Combination (NILC) foreground-cleaning method. We derive requirements on the relative calibration accuracy of the overall polarisation gain (Δg ν ) for each LiteBIRD frequency channel. Our results show that minimum variance techniques, as NILC, are less sensitive to systematic gain calibration uncertainties compared to a parametric approach, if the latter is not equipped with a proper modelling of these instrumental effects. In this study, the most stringent requirements are found in the channels where the CMB signal is relatively brighter, with the tightest constraints at 166 GHz (Δg ν ≈ 0.16%). This differs from the outcome of an analogous analysis performed with a parametric method, where the tightest requirements are obtained for the foreground-dominated channels. Gain calibration uncertainties, corresponding to the derived requirements, are then simultaneously propagated into all frequency channels. By doing so, we find that the overall impact on estimated r is lower than the total gain systematic budget for LiteBIRD approximately by a factor 5, due to the correlations of the impacts of gain calibration uncertainties in different frequency channels. In order to decouple the systematic effect from the specific choice of the model, we derive the requirements assuming constant spectral parameters for the foreground emission. To assess the robustness of the obtained results against more realistic scenarios, we repeat the analysis assuming sky models of intermediate and high complexity. In these further cases, we adopt an optimised NILC pipeline, called the Multi-Clustering NILC (MC-NILC). We find that the impact of gain calibration uncertainties on r is lower than the LiteBIRD gain systematics budget for the intermediate-complexity sky model. For the high-complexity case, instead, it would be necessary to tighten the requirements by a factor 1.8.

79 ASTRONOMY AND ASTROPHYSICS↗

NASA NTRS2019

New Horizons in Cosmology with Spectral Distortions of the Cosmic Microwave Background

Following the pioneering observations with COBE in the early 1990s, studies of the cosmic mi- crowave background (CMB) have primarily focused on temperature and polarization anisotropies. CMB spectral distortions – tiny departures of the CMB energy spectrum from that of a perfect blackbody – provide a second, independent probe of fundamental physics, with a reach deep into the primordial Universe. The theoretical foundation of spectral distortions has seen major advances in recent years, highlighting the immense potential of this emerging field. Spectral distortions probe a fundamental property of the Universe – its thermal history – thereby providing additional insight into processes within the cosmological standard model(I) (CSM) as well as new physics beyond. Spectral distortions are an important tool for understanding inflation and the nature of dark matter. They shed new light on the physics of recombination and reionization, both prominent stages in the evolution of our Universe, and furnish critical information on baryonic feedback processes, in addition to probing primordial correlation functions at scales inaccessible to other tracers. In principle the range of signals is vast: many orders of magnitude of discovery space can be explored by detailed observations of the CMB energy spectrum. Several CSM signals are predicted and provide clear experimental targets that are observable with present-day technology. Confirmation of these signals would extend the reach of the CSM by orders of magnitude in physical scale as the Universe evolves from the initial stages to its present form. Their absence would pose a huge theoretical challenge, immediately pointing to new physics. Here, we advocate for a dedicated effort to measure CMB spectral distortions at the largest angular scales (greater than approximately 1°) within the ESA Voyage 2050 Program. We argue that an L-class mission with a pathfinder would allow a precise measurement of all the expected CSM distortions. With an M-class mission, the primordial distortions (created at z >~ 10(exp 3)) would still be detected at modest significance, while the late-time distortions will continue to be measured to high accuracy. Building on the heritage of COBE/FIRAS, a spectrometer that consists of multiple, cooled (approximately equal to 0.1 K), absolutely-calibrated Fourier Transform Spectrometers (FTS) with wide frequency coverage (ν approximately equal to 10 GHz to a few x THz) and all-sky spectral sensitivity at the level of 0.1 0.5 Jy/sr would be the starting point for the M-class option. A scaled and further optimized version of this concept is being envisioned as the L-class option. Such measurements can only be done from space and would deliver hundreds of absolutely-calibrated maps of the Universe at large scales, opening numerous science opportunities for cosmology and astrophysics. This will provide independent probes of inflation, dark matter and particle physics, recombination and the energy output of our Universe from at late times, turning the long-standing spectral distortion limits of COBE/FIRAS into clear detections.

Chluba, J.↗

NASA NTRS2019

LiteBIRD: An All-Sky Cosmic Microwave Background Probe of Inflation

The LiteBIRD mission will map polarized fluctuations in the cosmic microwave background (CMB) to search for the signature of gravitational waves from inflation, potentially opening a window on the Universe a fraction of a second after the Big Bang. CMB measurements from space give access to the largest angular scales and the full frequency range to constrain Galactic foregrounds, and LiteBIRD has been designed to take best advantage of the unique window of space. LiteBIRD will have a powerful ability to separate Galactic foreground emission from the CMB due to its 15 frequency bands spaced between 40 and 402 GHz and sensitive 100-mK bolometers. LiteBIRD will provide stringent control of systematic errors due to the benign thermal environment at the second Lagrange point, L2, 20-K rapidly rotating half-wave plates on each telescope, and the ability to crosscheck its results by measuring both the reionization and recombination peaks in the B-mode power spectrum. LiteBIRD would be the next step in the series of CMB space missions, COBE, WMAP, and Planck, each of which has given landmark scientific discoveries.

Lee, Adrian T.↗

NASA NTRS2015

Update of Bisphosphonate Flight Experiment

Elevated bone resorption is a hallmark of human spaceflight and bed rest indicating that elevated remodeling is a major factor in the etiology of space flight bone loss. In a collaborative effort between the NASA and JAXA space agencies, we are testing whether an antiresorptive drug would provide additional benefit to in-flight exercise to ameliorate bone loss and hypercalciuria during long-duration spaceflight. Measurements of bone loss include DXA, QCT, pQCT, urinary and blood biomarkers. We have completed analysis of R+1year data from 7 crewmembers treated with alendronate during flight, as well as immediate post flight (R+<2wks) data from 6 of 10 concurrent controls without treatment. The treated astronauts used the Advanced Resistive Exercise Device (ARED) during their missions. The purpose of this report is twofold: 1) to report the results of inflight, post flight and one year post flight bone measures compared with available controls with and without the use of ARED; and 2) to discuss preliminary data on concurrent controls. The figure below compares the BMD changes in ISS crewmembers exercising with and without the current ARED protocol and the alendronate treated crewmembers also using the ARED. This shows that the use of ARED prevents about half the bone loss seen in early ISS crewmembers and that the addition of an antiresorptive provides additional benefit. Resorption markers and urinary Ca excretion are not impacted by exercise alone but are significantly reduced with antiresorptive treatment. Bone measures for treated subjects, 1 year after return from space remain at or near baseline. DXA data for the 6 concurrent controls using the ARED device are similar to DXA data shown in the figure below. QCT data for these six indicate that the integral data are consistent with the DXA data, i.e., comparing the two control groups suggests significant but incomplete improvement in maintaining BMD using the ARED protocol. Biochemical data of the concurrent control group await sample return and analysis. The preliminary conclusion is that an antiresorptive may be an effective adjunct to exercise during long-duration spaceflight.

LeBlanc, A.↗

NASA NTRS2011

Bisphosphonates as a Countermeasure to Space Flight Induced Bone Loss

This poster reviews the possibility of using Bisphosphonates to counter the bone loss that is experienced during space flight. The Hypothesis that is tested in this experiment is that the combined effect of anti-resorptive drugs plus in-flight exercise regimen will attenuate space flight induced loss in bone mass and strength and reduce renal stone risk. The experiment design, the status and the results are described.

LeBlanc, A.↗

NASA NTRS2009

Bisphosphonate as a Countermeasure to Space Flight-Induced Bone Loss

The purpose of this research is to determine whether anti-resorptive pharmaceuticals such as bisphosphonates, in conjunction with the routine in-flight exercise program, will protect ISS crewmembers from the regional decreases in bone mineral density and bone strength and the increased renal stone risk documented on previous long-duration space flights [1-3]. Losses averaged ~ 1 to 2 percent per month in such regions as the lumbar spine and hip. Although losses showed significant heterogeneity among individuals and between bones within a given subject, space flight-induced bone loss was a consistent finding. More than 90 percent of astronauts and cosmonauts on long-duration flights (average 171 days) aboard Mir and the ISS, had a minimum 5 percent loss in at least one skeletal site, 40 percent of them had a 10 percent or greater loss in at least one skeletal site, and 22 percent of the Mir cosmonauts experienced a 15 to 20 percent loss in at least one site. These losses occurred even though the crewmembers performed time-consuming in-flight exercise regimens. Moreover, a recent study of 16 ISS astronauts using quantitative computed tomography (QCT) demonstrated trabecular bone losses from the hip averaging 2.3 percent per month [4]. These losses were accompanied by significant losses in hip bone strength that may not be recovered quickly [5]. This rapid loss of bone mass results from a combination of increased and uncoupled remodeling, as demonstrated by increased resorption with little or no change in bone formation markers [6-7]. This elevated remodeling rate likely affects the cortical and trabecular architecture and may lead to irreversible changes. In addition to bone loss, the resulting hypercalciuria increases renal stone risk. Therefore, it is logical to attempt to attenuate this increased remodeling with anti-resorption drugs such as bisphosphonates. Success with alendronate was demonstrated in a bed rest study [8]. This work has been extended to space flight and two dosing regimens: 1) an oral dose of 70 mg of alendronate taken weekly during flight or 2) a single intravenous (IV) dose of 4 mg of zoledronic acid given several weeks before flight. Currently the study is focusing on the oral option because of NASA s safety concerns with the IV-administered drug. The protocol requests 10 male or female crewmembers on ISS flights of 90 days or longer. Controls are 16 previous ISS crewmembers with QCT scans of the hip performed by these same investigators. The primary outcome measure for this study is hip trabecular bone mineral density measured by QCT, but other measures of bone mass are performed including peripheral QCT (pQCT) and dual-energy x-ray absorptiometry. Serum and urinary bone markers and renal stone risk measured before, during, and after flight are included. Postflight data are currently being collected from 2 ISS crewmembers. Two additional crewmembers will return this spring after ~6-month missions. To date no untoward effects have been encountered.

Spector, Elisabeth↗